|
| |
| | | 54015 | | 27.02.1997 | | Ipsen Pharma Schweiz GmbH | | 06.07.2007 | | | | | | | | | | | 01.02.20. | | | | 01.02.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Naropin 2 mg/ml | Injektions-/Infusionslösung | Infusion solution (Ropivacaine Hydrochloride 2 mg/ml) | N01BB09 | | | 02 | Naropin 7.5 mg/ml | Injektionslösung | Injection solution (Ropivacaine Hydrochloride 7.5 mg/ml) | N01BB09 | | | 03 | Naropin 10 mg/ml | Injektionslösung | Injection solution (Ropivacaine Hydrochloride 10 mg/ml) | N01BB09 | | | 04 | Naropin 5 mg/ml | Injektionslösung | Injection solution (Ropivacaine Hydrochloride 5 mg/ml) | N01BB09 | |
|
|
|
